This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Journalology/ Peer Review/ Authorship  • Randomized Controlled Trial  • Neurology, Other  • Alert me on articles by topic

Arch Neurol. 2005;62:1042.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The editors and editorial board of the Archives of Neurology are implementing the requirement that all clinical trials be registered in a public trials registry as a condition for consideration for publication. This implementation is in support of the plan published by JAMA editor Catherine D. DeAngelis, MD, and editors from the International Committee of Medical Journal Editors (ICMJE) regarding clinical trial registration.¹ The ICMJE has recognized the need for device manufacturers and pharmaceutical corporations to register all clinical trials involving human subjects before recruiting participants.

We are in agreement with this policy as clinical trial registration will provide the public in general and our readers with the full range of clinical evidence on the reported clinical trial. Clinical trial registration will enhance the availability of not only the truth, but the whole truth. Selective reporting of only the positive outcomes of a new drug or device will be balanced . . . [Full Text of this Article]

AUTHOR INFORMATION

Roger N. Rosenberg, MD, Editor